drugset / Trial / NCT01872026
Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis
Non-randomizedParallel-groupOpen-labelOther
Summary
This study is to assess the safety, tolerability, plasma concentration and pharmacodynamics of ASP7991 after oral administration to patients with chronic kidney disease undergoing hemodialysis.
Timeline
- Start
- 2012-12-26
- Primary completion
- 2013-06-26
- Completion
- 2013-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP7991 | Unknown | — | Oral |
Indications
No indication recorded.